Skip to content

The Effect of Remote Postconditioning on Graft Function in Patients Undergoing Living-related Kidney Transplantation

The Effect of Remote Postconditioning on Graft Function in Patients Undergoing Living-related Kidney Transplantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01363687
Enrollment
60
Registered
2011-06-01
Start date
2011-08-31
Completion date
2012-05-31
Last updated
2013-12-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Reperfusion Injury, Kidney Transplantation, Remote Ischemic Postconditioning

Brief summary

The purpose of this study is to investigate whether upper limb ischemic postconditioning can improve renal function and decrease ischemic-reperfusion injury in patients undergoing living donor kidney transplantation.

Detailed description

Ischemic reperfusion injury after kidney transplantation is a common clinical problem associated with a high morbidity and mortality. To reduce the adverse effect of ischemic reperfusion injury after organ transplantation, various strategies including ischemic preconditioning or postconditioning. Remote ischemic postconditioning is one of such strategies where brief ischemic reperfusion injury of one organ protects other organs from sustained ischemic reperfusion injury. Remote ischemic postconditioning of the limb with a tourniquet is a safe and convenient method of postconditioning organs against ischemic reperfusion injury. However, the efficacy of remote ischemic postconditioning in patients undergoing living donor kidney transplantation needs to be established. Therefore, we investigate the efficacy of remote ischemic postconditioning of the upper limb with a tourniquet in recipients of kidney transplantation by measuring the markers of acute kidney injury.

Interventions

Remote ischemic postconditioning consists of three 5-min cycles of upper limb ischemia, which was induced by an automated cuff-inflator placed on the upper limb free of arteriovenous fistula and inflated to 250 mm Hg, with an intervening 5 min of reperfusion during which the cuff was deflated.

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Subjects undergoing elective living donor kidney transplantation * subjects older than 20 yrs who can give written informed consent

Exclusion criteria

* re-transplant recipients * those with peripheral vascular disease affecting the upper limbs free of arteriovenous fistula

Design outcomes

Primary

MeasureTime frameDescription
renal function of recipient after living-related kidney transplantation1 day before surgeryserum creatinine concentration and urine output

Secondary

MeasureTime frameDescription
Biomarkers of acute kidney injurybefore surgery and at 2, 6, 12 h after declaming of renal arterybiomarkers of acute kidney injury: Plasma cystatin-C, Urine IL-18, Urine Neutrophil gelatinase-associated lipocalin (NGAL)
Hemodynamic parametersbefore surgery and at 2, 6, 12, 24, 48, 72 h after declaming of renal arteryarterial blood pressure, heart rate, central venous pressure, pulse oximetry
outcome of kidney transplantationat 72 h after declaming of renal arterynumber of acute rejection or number of delayed graft function
postoperative hospital stayat postoperative day 60length of postoperative hospital stay (days)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026